SCHEMBL4927720

SCHEMBL4927720

Cc1ccc(C(=O)c2sc(S(C)(=O)=O)c3c2CC(C)(C)CC3=O)cc1

nearest known ligand 0.63

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.48
ALDH1A1 P00352 6/20 0.46
PKM P14618 2/20 0.46
BRD4 O60885 3/20 0.37
LMNA P02545 4/20 0.36
NPSR1 Q6W5P4 1/20 0.36
KMT2A Q03164 2/20 0.36
MAPT P10636 2/20 0.36
HPGD P15428 1/20 0.36
WRN Q14191 1/20 0.35
MAOB P27338 1/20 0.34
HSP90AA1 P07900 1/20 0.34
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
CA4 P22748 1/20 0.33
CA7 P43166 1/20 0.33
GAA P10253 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4928068 0.90 LRRK2 (0.47) LRRK2ALDH1A1PKMLMNANPSR1
SCHEMBL4924480 0.90 LRRK2 (0.47) LRRK2ALDH1A1PKMBRD4LMNA
SCHEMBL4928928 0.89 LRRK2 (0.47) LRRK2ALDH1A1PKMLMNANPSR1
SCHEMBL4919003 0.88 LRRK2 (0.46) LRRK2ALDH1A1PKMBRD4LMNA
SCHEMBL4929001 0.87 LRRK2 (0.45) LRRK2ALDH1A1PKMBRD4LMNA
SCHEMBL4928697 0.87 LRRK2 (0.45) LRRK2ALDH1A1PKMLMNANPSR1
SCHEMBL4927681 0.84 LRRK2 (0.45) LRRK2ALDH1A1PKMBRD4LMNA
SCHEMBL4917837 0.84 ALDH1A1 (0.43) LRRK2ALDH1A1PKMLMNANPSR1
SCHEMBL4923124 0.84 LRRK2 (0.45) LRRK2ALDH1A1PKMKMT2AMAPT
SCHEMBL4926093 0.84 ALDH1A1 (0.43) LRRK2ALDH1A1PKMLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists NOVO NORDISK A/S (DK) 2008-11-06 US disclosed
EP-1765814-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2007-03-28 EP disclosed
WO-2006003096-A1 CONDENSED THIOPHENE DERIVATIVES AND THEIR USE AS CYCLIC GLP-1 AGONISTS NOVO NORDISK A/S (DK) 2006-01-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275066-A1 Condensed Thiophene Derivatives and Their Use as Cyclic Glp-1 Agonists GLP1R, GIPR, GCGR LRRK2 327/4885ALDH1A1 2002/4885PKM 2177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.